Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.64 CHF | +1.03% | +4.63% | 0.00% |
May. 15 | Ten key beauty players | |
May. 10 | Europe sees two-speed IPO recovery as smaller deals lag | RE |
Sales 2024 * | 4.41B 4.01B | Sales 2025 * | 4.96B 4.51B | Capitalization | 19.36B 17.61B |
---|---|---|---|---|---|
Net income 2024 * | 206M 187M | Net income 2025 * | 468M 426M | EV / Sales 2024 * | 4.92 x |
Net Debt 2024 * | 2.31B 2.1B | Net Debt 2025 * | 1.81B 1.64B | EV / Sales 2025 * | 4.27 x |
P/E ratio 2024 * |
93.1
x | P/E ratio 2025 * |
39.3
x | Employees | - |
Yield 2024 * |
0.12% | Yield 2025 * |
0.34% | Free-Float | 0% |
Latest transcript on Galderma Group AG
1 day | +0.78% | ||
1 week | +4.46% | ||
Current month | +8.79% | ||
1 month | +11.26% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 74.64 | +1.03% | 136 214 |
24-05-17 | 73.88 | -1.27% | 152,399 |
24-05-16 | 74.83 | +2.51% | 304,091 |
24-05-15 | 73 | +2.33% | 205,630 |
24-05-14 | 71.34 | +1.91% | 285,431 |
Delayed Quote Swiss Exchange, May 21, 2024 at 09:25 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 19.32B | |
+20.12% | 20.76B | |
+11.99% | 12.59B | |
-15.78% | 9.03B | |
+23.93% | 8.1B | |
+9.36% | 5.93B | |
-3.79% | 4.46B | |
-17.38% | 3.81B | |
-5.36% | 3.59B | |
-9.91% | 3.59B |
- Stock Market
- Equities
- GALD Stock